Get the Stockscreener App
1.1586
0.43%
-0.0014
Shattuck Labs Inc stock is traded at $1.1586, with a volume of 108.60K.
It is down -0.43% in the last 24 hours and down -5.33% over the past month.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
See More
Previous Close:
$1.16
Open:
$1.14
24h Volume:
108.60K
Relative Volume:
0.19
Market Cap:
$55.36M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.5339
EPS:
-2.17
Net Cash Flow:
$-70.93M
1W Performance:
-13.81%
1M Performance:
-5.33%
6M Performance:
-89.29%
1Y Performance:
-37.57%
1-Day Range:
$1.14
$1.22
1-Week Range:
$1.13
$1.38
52-Week Range:
$1.07
$11.76
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Vanguard Group Inc's Strategic Acquisition in Shattuck Labs Inc - GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc.STTK - PR Newswire
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in October - Defense World
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Shareholders to Connect - AccessWire
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Significant Drop in Short Interest - MarketBeat
Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Stockholders to Inquire about Securities Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Stockholders to Connect - AccessWire
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - PR Newswire
Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Shattuck Labs Inc [STTK] Investment Guide: What You Need to Know - Knox Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Investors to Inquire about Securities Investigation - AccessWire
Marshall Wace LLP Sells 8,453 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Layoff Tracker: Medtronic, CareFusion Laying Off Over 400 Combined Employees - BioSpace
Shattuck Labs Inc [STTK] Shares Rise 11.11 % on Wednesday - Knox Daily
GXO Logistics, Momentus, Shattuck Labs: 3 Stocks Retail Investors Are Most Bullish On Today - Barchart
There is no doubt that Shattuck Labs Inc (STTK) ticks all the boxes. - SETE News
Shattuck Labs CEO buys $44.2k in company shares - Investing.com India
Shattuck Labs, Inc. (NASDAQ:STTK) CEO Taylor Schreiber Purchases 36,500 Shares - MarketBeat
How did Shattuck Labs Inc (STTK) fare last session? - US Post News
Shattuck Labs CEO buys $44.2k in company shares By Investing.com - Investing.com Canada
After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK) - Yahoo Finance
Shattuck Labs stock hits 52-week low at $1.15 amid market challenges - Investing.com Canada
Shattuck Labs stock hits 52-week low at $1.15 amid market challenges By Investing.com - Investing.com South Africa
Investing in Shattuck Labs Inc (STTK) Is Getting More Attractive - Knox Daily
Shattuck Labs Inc’s Shares Reel: -65.63% Quarterly Revenue Decline Amid 58.23M Market Cap - The InvestChronicle
Shattuck Labs, Inc. (NASDAQ:STTK) Stock Position Lifted by Renaissance Technologies LLC - Defense World
American Century Companies Inc. Grows Stock Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Evercore ISI Upgrades Shattuck Labs (NASDAQ:STTK) to Strong-Buy - MarketBeat
Shattuck Labs’ stock craters as biotech scraps main product candidate after failed trial - MSN
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Shattuck Labs, Inc. (STTK) - The Globe and Mail
It makes sense and dollars to buy Shattuck Labs Inc (STTK) stock - SETE News
Shattuck Labs, Inc. Forecasted to Earn Q3 2024 Earnings of ($0.35) Per Share (NASDAQ:STTK) - MarketBeat
HC Wainwright Comments on Shattuck Labs, Inc.’s Q3 2024 Earnings (NASDAQ:STTK) - Defense World
Kaplan Fox & Kilsheimer LLP is Investigating Shattuck Labs, Inc. (STTK) for Potential Securities Law Violations - The Globe and Mail
Shattuck Labs Inc [STTK] is -73.07% lower this YTD. Is it still time to buy? - The DBT News
Shattuck Labs Inc (STTK) receives a Neutral rating from H.C. Wainwright - Knox Daily
Shattuck Labs stock craters following pipeline and job cuts - Yahoo Finance
Shattuck Labs to focus on DR3 antagonist antibody for IBD - BioWorld Online
Shattuck stock cut at Citi on program exit (NASDAQ:STTK) - Seeking Alpha
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls - Yahoo Finance
Shattuck Labs to lay off 40 percent of workforce - PharmaLive
Shattuck Labs (NASDAQ:STTK) Downgraded by Citigroup - MarketBeat
Shattuck Labs (NASDAQ:STTK) Downgraded to “Neutral” at Citigroup - Defense World
Shattuck Labs (NASDAQ:STTK) Rating Lowered to Hold at Needham & Company LLC - Defense World
Will Shattuck Labs (NASDAQ:STTK) Spend Its Cash Wisely? - Simply Wall St
Post-Trade Analysis: Shattuck Labs Inc (STTK) Slides -44.99, Closing at 1.92 - The Dwinnex
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brous Tyler | Director |
Jun 27 '24 |
Buy |
3.89 |
5,416 |
21,068 |
235,088 |
| Brous Tyler | Director |
Jun 28 '24 |
Buy |
3.90 |
3,000 |
11,700 |
238,088 |
| Schreiber Taylor | Chief Executive Officer |
Jun 26 '24 |
Buy |
3.47 |
14,400 |
50,011 |
34,502 |
| Schreiber Taylor | Chief Executive Officer |
Jun 04 '24 |
Option Exercise |
3.57 |
3,050 |
10,888 |
20,102 |
| Stout Stephen | See Remarks |
Mar 06 '24 |
Option Exercise |
3.54 |
11,109 |
39,380 |
85,791 |
| Stout Stephen | See Remarks |
Mar 06 '24 |
Sale |
10.53 |
16,004 |
168,522 |
74,437 |
| Neill Andrew R | Chief Financial Officer |
Jan 10 '24 |
Sale |
10.00 |
25,000 |
250,000 |
173,446 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):